Nautilus Biotechnolgy
NAUT
NAUT
67 hedge funds and large institutions have $114M invested in Nautilus Biotechnolgy in 2025 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.27% more ownership
Funds ownership: 45.84% → 46.12% (+0.27%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1% less funds holding
Funds holding: 68 → 67 (-1)
Holders
67
Holding in Top 10
3
Calls
$5K
Puts
$1K
Top Buyers
| 1 | +$1.23M | |
| 2 | +$605K | |
| 3 | +$295K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$273K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$192K |
Top Sellers
| 1 | -$1.23M | |
| 2 | -$335K | |
| 3 | -$254K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$222K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$215K |
